Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Disease-free Survival Rate”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Testing effectiveness (Phase 2)UnknownNCT04102982
What this trial is testing

Microwave Ablation in Combination With Camrelizumab Versus Camrelizumab in Metastatic Non-small-cell Lung Cancer

Who this might be right for
NSCLC Stage IV
Shandong Provincial Hospital 200
Testing effectiveness (Phase 2)Study completedNCT01130337
What this trial is testing

Capecitabine [Xeloda] in Combination With Trastuzumab [Herceptin] and Oxaliplatine in Patients With Resectable Gastric Cancer

Who this might be right for
Gastric Cancer
Hoffmann-La Roche 36
Very early researchUnknownNCT03900871
What this trial is testing

Clinical Research on the Effect of Aspirin on the Disease Free Survival Rate of Esophageal Carcinoma

Who this might be right for
Aspirin as an Adjuvant Therapy, to Observe Its Effect on the Disease Free Survival Rate of Patients With Esophageal Squamous Cell Carcinoma
Hebei Medical University Fourth Hospital 600
Not applicableEnded earlyNCT03412630
What this trial is testing

Perfusion CT in Predicting Outcomes in Ovarian, Fallopian, or Peritoneal Cancer With Bevacizumab

Who this might be right for
Recurrent Fallopian Tube CarcinomaRecurrent Ovarian CarcinomaRecurrent Primary Peritoneal Carcinoma
ECOG-ACRIN Cancer Research Group 1
Not applicableUnknownNCT03892577
What this trial is testing

Real-world Study for Patients With Advanced Hepatobiliary Tumors

Who this might be right for
Objective Response RateProgression-free SurvivalOverall Survival+4 more
Peking Union Medical College Hospital 3,000
Testing effectiveness (Phase 2)Study completedNCT00748358
What this trial is testing

An Open-label Phase II Study With SUTENT in Patients Suffering From Hormone Refractory Prostate Cancer

Who this might be right for
Prostatic NeoplasmsNeoplasms, Hormone-DependentTumor Markers, Biological+2 more
Assistance Publique - Hôpitaux de Paris 50
Testing effectiveness (Phase 2)Study completedNCT00109005
What this trial is testing

Lenalidomide (Revlimid) to Treat Advanced Ocular Melanoma

Who this might be right for
Melanoma
National Cancer Institute (NCI) 17
Testing effectiveness (Phase 2)UnknownNCT04699214
What this trial is testing

Endostar Combined With AI Regimen Compared With AI in Adjuvant Treatment

Who this might be right for
Other Disorders of Soft Tissues
Yong Chen 210
Testing effectiveness (Phase 2)UnknownNCT04664244
What this trial is testing

Combination of Nimotuzumab and Radiotherapy for Recurrent Uterine Cervical Squamous Carcinoma

Who this might be right for
Recurrent Cervical CarcinomaRadiotherapyEpidermal Growth Factor Receptor+4 more
Lei Li 43
Large-scale testing (Phase 3)Study completedNCT00970138
What this trial is testing

Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer

Who this might be right for
Gastric Carcinoma
Fudan University 141
Not applicableStudy completedNCT05754047
What this trial is testing

Tumor Characteristics and Survival Rate of HER2-Low Breast Cancer Patients

Who this might be right for
HER2 Low Breast Carcinoma
Mahdis Bayat 3,582
Not applicableUnknownNCT06050447
What this trial is testing

Factors Affecting the Results of Treatment of Patients With Colorectal Cancer

Who this might be right for
Colorectal CancerColon CancerRectal Cancer+3 more
Immanuel Kant Baltic Federal University 1,200
Not applicableUnknownNCT05310305
What this trial is testing

PD-1 Antibody and Radiotherapy for Recurrent Cervical Cancer

Who this might be right for
Immune Checkpoint InhibitorsAnti-programmed Death-1 AntibodyRadiotherapy+7 more
Lei Li 20
Testing effectiveness (Phase 2)UnknownNCT01192230
What this trial is testing

Study of Endostatin Combined With Docetaxel in the Treatment of Advanced Non-small Cell Lung Cancer Patients

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Fudan University 30
Not applicableUnknownNCT02140034
What this trial is testing

Extensive Peritoneal Lavage After Curative Gastrectomy for Gastric Cancer: A Randomised Controlled Trial

Who this might be right for
Gastric Cancer
National University Hospital, Singapore 600
Not applicableStudy completedNCT07442110
What this trial is testing

This Observational Study Evaluates the Clinical Outcomes of Patients With Diabetes Who Utilize a Specialized Dietary Supplements for Foot Ulcer Healing. The Study Documents the Rate of Complete Wound Closure and the Prevention of Lower Extremity Amputations in a Real-world, At-home Setting.

Who this might be right for
Limb SalvageDiabetes ComplicationDietary Supplements+6 more
Amar h Zireg 35
Not applicableUnknownNCT00449319
What this trial is testing

AML Treatment in Untreated Adult Patients

Who this might be right for
Leukemia, Myelocytic, Acute
Gruppo Italiano Malattie EMatologiche dell'Adulto
Testing effectiveness (Phase 2)Ended earlyNCT01466868
What this trial is testing

Study of MK 2206 in Patients With Relapsed or Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B Cell Lymphoma
Centre Leon Berard 22
Not applicableStudy completedNCT05307926
What this trial is testing

Postoperative Adjuvant Therapy of HCC Based on PD-1

Who this might be right for
Hepatocellular CarcinomaRFS
Chen Xiaoping 573
Testing effectiveness (Phase 2)Ended earlyNCT00474188
What this trial is testing

Evaluate Lenalidomide Combined With Dexamethasone in Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene Corporation 26
Next Page